Entod Pharma gets DCGI nod for phase 3 trials of Atropine eye drops Ruchika Sharma31 May 2022 7:57 AM GMT"Low-Dose Atropine eye drops is one of the most viable therapeutic option available to slow down the progression of myopia rapidly and improve a...
